Xiao Hu
-
- Cancer Treatment and Pharmacology 4
- Colorectal Cancer Treatments and Studies 3
- Pancreatic and Hepatic Oncology Research 2
-
- MicroRNA in disease regulation 5
-
- Extracellular vesicles in disease 5
-
- Lung Cancer Treatments and Mutations 3
-
- Hepatocellular Carcinoma Treatment and Prognosis 2
-
- IL-33, ST2, and ILC Pathways 2
- Journals
- SHILAP Revista de lepidopterología (1 paper)International Journal of Molecular Sciences (1 paper)Annals of Oncology (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xiao Hu
24 papers receiving 277 citations
Peers
Comparison fields: 5 of 67
- Otorhinolaryngology 21
- Health Informatics 6
- Oncology 108
- Nephrology 23
- Cancer Research 48
Countries citing papers authored by Xiao Hu
This map shows the geographic impact of Xiao Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao Hu more than expected).
Fields of papers citing papers by Xiao Hu
This network shows the impact of papers produced by Xiao Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao Hu. The network helps show where Xiao Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiao Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 4 | |
| 3 | 2024 | 7 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 3 | |
| 10 | 2022 | 10 | |
| 11 | 2022 | 6 | |
| 12 | 2022 | 1 | |
| 13 | 2022 | 9 | |
| 14 | 2022 | 24 | |
| 15 | 2022 | 3 | |
| 16 | 2021 | 29 | |
| 17 | 2021 | 14 | |
| 18 | 2020 | 27 | |
| 19 | 2016 | 62 | |
| 20 | [Phase II clinical trial of nedaplatin in advanced non-small cell lung cancer]. | 2002 | 4 |
About Xiao Hu
Xiao Hu is a scholar working on Cancer Research, Hepatology and Transplantation, having authored 24 papers that have together received 279 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (5 papers), MicroRNA in disease regulation (5 papers), Cancer Treatment and Pharmacology (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), IL-33, ST2, and ILC Pathways (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Otorhinolaryngology (21 citations), Health Informatics (6 citations) and Oncology (108 citations). Xiao Hu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Ning Na, Jiang Qiu, Tong Zheng, Jinhua Zhang, You Luo, Rui‐Hua Xu, Bin Miao, Yingcheng Lin, Jun Jia and Jiewen Peng. Their work appears in journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.